Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Fujifilm and Merck & Co. have formed a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a contract biopharmaceutical manufacturing and development business of Merck.

Merck Sells Contract Biopharmaceutical Business to Fujifilm

Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.

Week of Feb. 28, 2011: Company and People Notes: Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.

Brazil develops its first national plasma fractionation plant.

Report From Brazil March 2011

Q&A with Robert Hardy, chief executive of Aesica

Q&A with Robert Hardy, Aesica

The power of emerging markets is reflected in the pharma's sales and production positions.

A Focus on Emerging Markets

INTERPHEX 2011 aims to address the industry's unique characteristics.

Innovation, Intelligence, Passion

The authors outline the key decision points FDA must consider in putting forth a US regulatory pathway for biosimilars.

The US Biosimilar Regulatory Scheme and Comparison with the European Experience: Where Do Where Go From Here?

This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.

Drug Development for Government, Nonprofit, and Developing-World Markets

Contract manufacturers and fine-chemical suppliers announce capacity expansions and service enhancements of Informex.

A Roundup of Informex

The Society of Chemical Manufacturers and Affiliates (SOCMA), in a statement submitted to the US House Subcommittee on Cybersecurity, Infrastructure Protection and Security Technologies, called for Congressional action to pass a three-to-five year authorization of current Chemical Facility Anti-Terrorism Standards (CFATS), which are scheduled to expire Mar. 4, 2011.

Ingredients